STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

430 Schedule 13G/A filing by Vanguard Group

Vanguard Group reported beneficial ownership of 11 shares, representing 12% of TERNS PHARMACEUTICALS INC in this filing.

FiledMar 27, 2026
Ownership dateMar 13, 2026
Reported shares11
Reported ownership12%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 7
Shared voting power 8
Sole dispositive power 9
Shared dispositive power 10
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Vanguard Group
CIK
CIK0000102909
Accession
0000102909-26-002421
Form
Schedule 13G/A
Open SEC filing View 430 ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →